E-submission
Search
- Page Path
- HOME > Search
Original Article
- Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder Carcinoma.
- Sung Im Do, Gou Young Kim, Sung Jig Lim, Youn Wha Kim
- Korean J Pathol. 2010;44(1):42-47.
- DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.1.42
- 3,080 View
- 17 Download
- 1 Crossref
-
Abstract
PDF - BACKGROUND
Cyclooxygenase-2 (COX-2) is an enzyme that promotes proliferation of tumor cells. HuR is a member of the family of embryonic lethal abnormal vision-like proteins. Recent studies show that cytoplasmic HuR stabilizes the mRNA of COX-2 and regulates the expression of COX-2. Moreover, cytoplasmic HuR expression is associated with a poorer prognosis for patients with some cancers. The aim of this study was to investigate the expression patterns of and the relationship between COX-2 and HuR in gallbladder carcinoma.
METHODS
We analyzed COX-2 and HuR expression by immunohistochemical staining of 108 gallbladder carcinomas.
RESULTS
COX-2 expression and nuclear and cytoplasmic HuR expression were seen in, respectively, 61 (56.5%), 77 (71.3%), and 4 (3.7%) cases. COX-2 and nuclear HuR were simultaneously expressed in 44 of the 108 samples without any quantitative association between the levels of each. COX-2 expression correlated with tumor stage, differentiation (based on histology), lymph node metastasis, perineural invasion, and survival. Nuclear and cytological expression of HuR did not correlate with any clinical parameters.
CONCLUSIONS
COX-2 expression but not HuR may play an important role in the prognosis of patients with gallbladder carcinoma. -
Citations
Citations to this article as recorded by
- Prognostic Molecular Markers in Resected Extrahepatic Biliary Tract Cancers; A Systematic Review and Meta-Analysis of Immunohistochemically Detected Biomarkers
Robert P Jones, Nicholas TE Bird, Richard A Smith, Daniel H Palmer, Steven W Fenwick, Graeme J Poston, Hassan Z Malik
Biomarkers in Medicine.2015; 9(8): 763. CrossRef
- Prognostic Molecular Markers in Resected Extrahepatic Biliary Tract Cancers; A Systematic Review and Meta-Analysis of Immunohistochemically Detected Biomarkers
First
Prev
